v3.25.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating activities    
Net loss $ (6,529) $ (20,239)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization expense 5,678 5,248
Stock-based compensation expense 3,983 (451)
Change in fair value of warrants 1,100 6,101
Deferred tax expense 447 (82)
Change in third party payor reserves 1,395 (193)
Other 757 886
Change in operating assets and liabilities:    
Accounts receivable (8,557) 4,220
Inventory (2,032) (2,877)
Accounts payable and accrued expenses 10,824 (4,733)
Other assets and liabilities 3,116 (4,293)
Net cash provided by (used in) operating activities 10,182 (16,413)
Investing activities    
Purchases of property and equipment (6,129) (443)
Purchases of marketable securities (17,209) (5,167)
Proceeds from sales of marketable securities 0 598
Proceeds from maturities of marketable securities 13,930 5,855
Net cash (used in) provided by investing activities (9,408) 843
Financing activities    
Proceeds from offerings, net of issuance costs 13,894 0
Exercise of stock options 735 24
Long-term debt principal payments (300) 0
Finance lease payoff and principal payments (611) (462)
Net cash provided by (used in) financing activities 13,718 (438)
Net increase (decrease) in cash, cash equivalents and restricted cash 14,492 (16,008)
Cash, cash equivalents and restricted cash, at beginning of period 86,202 100,668
Cash, cash equivalents and restricted cash, at end of period 100,694 84,660
Supplemental disclosures of cash flow information    
Cash paid for interest 1,600 2,019
Cash paid for taxes 206 300
Purchases of property and equipment in accounts payable and accrued expenses $ 2,197 $ 36